Branded vs. Generics

NOV 2016

Issue link:

Contents of this Issue


Page 0 of 22

November 2016 Evaluating efficacy, adherence, and cost in today's healthcare environment Balancing Cost & Care - in 2017 - What Makes an Ophthalmic Generic Bioequivalent? Multifactorial Choices in Glaucoma Forecasting Drug Trends and Innovations How Cost Affects Drug Choices for Patients and Physicians WHAT'S INSIDE:

Articles in this issue

Archives of this issue

view archives of Branded vs. Generics - NOV 2016